Professional Education

  • Doctor of Philosophy, University of Nevada Las Vegas (2019)
  • Bachelor of Science, Juniata College (2012)

Stanford Advisors


All Publications

  • The Design, Synthesis, and Characterizations of Spore Germination Inhibitors Effective against an Epidemic Strain of Clostridium difficile JOURNAL OF MEDICINAL CHEMISTRY Sharma, S. K., Yip, C., Esposito, E., Sharma, P. V., Simon, M. P., Abel-Santos, E., Firestine, S. M. 2018; 61 (15): 6759?78


    Clostridium difficile infections (CDI), particularly those caused by the BI/NAP1/027 epidemic strains, are challenging to treat. One method to address this disease is to prevent the development of CDI by inhibiting the germination of C. difficile spores. Previous studies have identified cholic amide m-sulfonic acid, CamSA, as an inhibitor of spore germination. However, CamSA is inactive against the hypervirulent strain R20291. To circumvent this problem, a series of cholic acid amides were synthesized and tested against R20291. The best compound in the series was the simple phenyl amide analogue which possessed an IC50 value of 1.8 ?M, more than 225 times as potent as the natural germination inhibitor, chenodeoxycholate. This is the most potent inhibitor of C. difficile spore germination described to date. QSAR and molecular modeling analysis demonstrated that increases in hydrophobicity and decreases in partial charge or polar surface area were correlated with increases in potency.

    View details for DOI 10.1021/acs.jmedchem.8b00632

    View details for Web of Science ID 000441484300020

    View details for PubMedID 30004695

    View details for PubMedCentralID PMC6192251

Footer Links:

Stanford Medicine Resources: